Evidence map›Paper›PMID 41464807›Full record

ReviewJournal of clinical medicine2025

Paravalvular Leak After Transcatheter Aortic Valve Replacement (TAVR): A Literature Review.

Giorgio Sciaramenti, Edoardo Menzato, Stefano Clo', Carmen Izzo, Laura Rotondo, Beatrice Dal Passo, Sofia Meossi, Renè Tezze, Federica Frascaro, Elisabetta Tonet and 6 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Giorgio SciaramentiCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.
Edoardo MenzatoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0009-0001-3438-5696
Stefano Clo'Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-4169-2977
Carmen IzzoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0009-0000-5695-9147
Laura RotondoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0009-0004-1438-775X
Beatrice Dal PassoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-5515-853X
Sofia MeossiCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.
Renè TezzeCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.
Federica FrascaroCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0009-0008-3166-0542
Elisabetta TonetCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.
Federico MarchiniCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0003-2622-4881
Marta CoccoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-4280-5232
Carlo TumscitzCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.
Carlo PenzoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0001-7106-5731
Gianluca CampoCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-5150-188X
Rita PavasiniCardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.ORCID 0000-0002-1763-9711

Funding

Italian Health Minister GR-2021-12374295
6 · The paper itself

Abstract

Severe aortic stenosis represents a significant prognostic burden, particularly in symptomatic patients. The advent of transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of patients previously considered ineligible for surgical aortic valve replacement (SAVR). TAVR provides a relatively safe intervention that leads to improvements in survival, symptoms, and functional status within months of implantation. A major complication following TAVR is the occurrence of paravalvular leaks (PVLs), which have been associated with increased mortality and higher rates of heart failure-related hospitalizations. PVLs refer to abnormal blood flow between the implanted valve and the aortic wall, which can compromise the functionality of the device. Careful pre-procedural planning enables the identification of patients at higher risk for PVL development. Although the incidence of PVLs has decreased with the introduction of newer-generation transcatheter valves, the condition remains clinically relevant. Due to the complex anatomy of the aortic valve apparatus and interference from the prosthetic frame, accurate evaluation of PVLs requires a multimodal diagnostic approach. Current evidence on PVL management is limited. In most cases, a conservative approach is adopted, while interventional strategies (such as pre- and post-dilatation, percutaneous PVL closure, and TAVR-in-TAVR) are reserved for selected patients. We performed a systematic literature review to summarize the incidence, predictors, diagnostic techniques, and management strategies of PVLs following TAVR.

Indexed as

aortic regurgitationleakparavalvular leakTAVR

Identifiers

PMID41464807
PMCPMC12733503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.